MARSHALL WACE, LLP - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X118. A total of 17 filers reported holding THE ONCOLOGY INSTITUTE INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2022$290,000
-7.6%
62,506
+0.0%
0.00%0.0%
Q2 2022$314,000
-29.3%
62,4920.0%0.00%0.0%
Q1 2022$444,000
-27.2%
62,4920.0%0.00%0.0%
Q4 2021$610,000
-1.6%
62,4920.0%0.00%
-66.7%
Q3 2021$620,00062,4920.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
LMR Partners LLP 1,568,564$1,063,3300.02%
DIFESA CAPITAL MANAGEMENT, LP 115,975$10,9940.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,250,000$81,3750.00%
Alpine Global Management, LLC 25,024$1,5160.00%
COWEN AND COMPANY, LLC 120,300$7,8310.00%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 262,751$250.00%
Man Group plc 94,740$9,3790.00%
Citadel Advisors 17,307$1,6410.00%
BANK OF AMERICA CORP /DE/ 100$60.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders